Stock Report for LifeVantage Corp. (LFVN)
  • Stock Alert for Bank of America Corp. (BAC)
  • Stock Alert for Central European Distribution Corp. (CEDC)
  • " />

    Stock Alert for LifeVantage Corp. (LFVN)

    LifeVantage Corp. (LFVN) is a science-based company engaged in the identification, research, development, manufacture and distribution of an advanced nutraceutical dietary supplement, Protandim, and an anti-aging skin care product, LiveVantage TrueScience, to meet important health and wellness needs. The Company is focusing its ongoing research efforts on oxidative stress solutions, particularly the activation of Nuclear factor (erythroid-derived 2)-like 2, also known as Nrf2, as it relates to cardiovascular, central nervous system, inflammatory and metabolic diseases, and other health-related disorders. LFVN sells its products in the United States, Japan, Mexico and Canada, through a network of independent distributors, preferred, retail and direct customers.

    Share Statistics (08-Feb-12) FY2010 FY2011 % Chg Q32010 Q32011 % Chg
    Symbol LFVN Revenue, $Mn 11.48 38.92 239.0% 6.44 20.08 211.8%
    Current price $1.87 Gross marg. 83.4% 84.8% 1.7% 84.2% 85.3% 1.3%
    52wk Range: $1.69-$1.92 Oper. margin 9.5% 17.1%
    Avg Vol (3m): n/a Net margin -96.3% -130.5% 35.5% 11.2% 18.5% 65.2%
    Market Cap. 185.68M
    Shares Outstanding 99.30M EPS, $ -0.19 -0.69 263.2% 0.01 0.03 200.0%

    Source:, SEC Filings.

    Investment Highlights

    Shares in LifeVantage Corp. (LFVN) jumped as much as 17% Wednesday, continuing on its winning streak for the fourth straight day.  Over 1.78 million shares have traded hands during the session, versus the 30-day average volume of about over 173 K.

    LFVN shares have gained 29.9% in the last five days; 37.5% in the last month; and 175.0% year-to-date.

    LFVN shares spiked last month as investors welcomed the news of the Company’s addition of new directors to its board at a January 10 annual shareholders meeting. The Company announced that four new board members were elected and the board immediately held a meeting after the shareholders meeting was completed. Woody Spedden was appointed as chairman of the board at that meeting.

    Having held leadership positions at successful companies including Apple, VISA, Coca-Cola, Textron and Hewlett-Packard, the new directors are seen to bring a wealth of corporate experience and expertise in areas that are critically important to the LFVN’s growth and long-term success.

    Douglas C. Robinson, CEO of LFVN, commented: “Each of our new directors brings a unique and valuable perspective that will be instrumental as we grow our business through distributor growth, geographic expansion, and the strategic introduction of new and complementary products.

    LFVN’s board now consists of nine members, six of whom are independent.

    Also last month, the Company announced that it had received the expected approval from warrant holders of its tender offer to modify certain outstanding warrants.  With the warrant modification and the expiration of certain other warrants in March and April 2012, LFVN will be removing all derivative warrant liabilities from its balance sheet and eliminating the quarterly changes in fair value of these warrants from its income statement. With these changes, the Company believes that its financial statements will more closely reflect its operating performance.

    The Company is expected to release its fiscal 2012 second quarter financial results on February 14, 2012, after the closing bell.

    LFVN added $0.23, or 14.02%, to close Wednesday trade at $1.87.


    Financial Summary

    LFVN reported net revenue of $20.1 million for the first fiscal quarter ended September 30, 2011, a record increase of 214% from $6.4 million reported in comparable period of the prior year.  On a sequential basis, net revenue increased 34% from the $15.0 million reported for the fiscal 2011 fourth quarter ended June 30, 2011.

    Gross profit for the latest reported quarter rose to $17.1 million compared to $5.4 million for the same period last year, delivering a gross margin of 85%, compared to 84% for the same period last year

    Net income for the quarter came in at $3.7 million, compared to $0.7 million in the same period of the prior year and a net loss of $47.2 million in the prior quarter. According to the Company, the result reflects the increase in revenue, leverage of operating expenses and a decrease in interest expense due to the shareholders’ conversion of convertible debentures and reduced derivative expenses.

    LFVN’s cash balance at September 30, 2011, was $9.4 million, an increase from $6.4 million at year end fiscal 2011, attributable to strong revenue growth and operating profits. The Company generated $3.3 million of cash flow from operations in the first quarter of fiscal 2012 compared to $0.6 million in the first quarter of fiscal 2011.

    Looking forward to fiscal 2012, the Company expects to report revenue in a range of $95 million to $105 million, up from its previous guidance of $80 million to $90 million. Operating income is expected to be in a range of $11.4 million to $14.7 million, ahead of its previous guidance of $8.0 million to $9.5 million.


    Financial Strength (08-Feb-2012)




    S&P 500

    Quick Ratio (MRQ) 0.84 1.94 1.82 0.59
    Current Ratio (MRQ) 1.04 2.49 2.32 0.92
    LT Debt to Equity (MRQ) 10.42 29.63 95.13
    Total Debt to Equity (MRQ) 16.36 39.72 134.18
    Interest Coverage (TTM) -0.43 0.07 2.53 27.70

    Source:, SEC Filings.

    Technical Analysis


    LFVN is above the upper Bollinger Band, implying that it is currently extended from its recent trend. Be aware, however, that a cross outside of the Bollinger Bands can sometimes be a signal of trend strength and not, necessarily, trend reversal.

    The MACD for LFVN currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0, which implies that the underlying moving averages are trending higher.

    Comparative Analysis

    Company Name Ticker Price per Mrkt. Cap. P/E P/S
    Feb08-2011 symbol Share, $ $ Mn 2011 2012 2011 2012
    Inyx Inc. IYXI 0.0012 63.73K n/a n/a n/a n/a
    Prestige Brands Holdings Inc. PBH 13.46 676.38M 14.02 11.70 1.62 1.21
    Drug Related Products Median       18.61 n/a 1.05 n/a
    Lifevantage Corp. LFVN 1.87 185.68M n/a n/a n/a n/a

    Source: Thomson Financial

    DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

    The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

    Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

    Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

    Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

    We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

    To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

    We encourage you to invest carefully and read investment information available at the websites of the SEC at and FINRA at

    Leave a Reply

    Your email address will not be published. Required fields are marked *